Huaxi Bio: the plan of reducing 1% shares of shareholders Yingrui Wuyuan has been implemented
Huaxi biological announced that from June 29 to July 16, the shareholder Yingrui Wuyuan reduced 4.8 million shares of the company through centralized bidding transaction, accounting for 1% of the total shares of the company, and the reduction price range was 264.366-314.278 yuan / share. The reduction plan has been implemented.
This text is a result of machine translation.
Related companies：
Briefing Mar 10, 2022 09:18 PM
· Healthcare
Polish President: the issue of providing fighters to Ukraine should be jointly decided by NATO countries
In-depth
Briefing Mar 09, 2022 07:19 PM
Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Apr 18, 2022 06:30 PM
Apr 11, 2022 08:42 PM
Briefing Dec 09, 2021 10:39 AM
Baijiu plate strength, mouth cellar line exceeds 10%
Briefing Oct 29, 2021 11:38 AM
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.
Briefing Sep 24, 2021 11:28 AM
· Healthcare
The medical and American plate rose sharply
See more
Read next
In-depth
In-depth
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.